T.H.A.C

T.H.A.C is a passionate biopharmaceutical company. T.H.A.C was founded on 25 years of research initiated by our CEO, Pr. Christian Bréchot, and driven by a team of experts in complementary fields. Established in 2018, the company is headquartered in Paris with a subsidiary in Tampa, Florida. The founders have built an operational R&D team, supported by experienced consultants, a strategic committee, and independent medical experts to ensure the successful development of our molecule, ALF-5755.